Fitwel Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.73 Cr
as on 14-12-2024
- Revenue 7.85%
(FY 2024)
- Profit -30.31%
(FY 2024)
- Ebitda -27.54%
(FY 2024)
- Net Worth 33.02%
(FY 2024)
- Total Assets 37.09%
(FY 2024)
About Fitwel Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.73 Cr.
Chandra Jain, Bhavik Jain, Bhupendra Jain, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233MH2014PTC256071
- Company No.
256071
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jul 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Fitwel Pharmaceuticals Private Limited offer?
Fitwel Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Injection, Digestive System Drugs & Medicines, Antacid Drugs, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Anti Infective Agent, Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Antibacterial Drugs.
Who are the key members and board of directors at Fitwel Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandra Jain  | Director | 01-Sep-2015 | Current |
| Bhavik Jain | Director | 15-Jul-2014 | Current |
| Bhupendra Jain | Director | 15-Jul-2014 | Current |
| Kshitij Jain | Director | 01-Sep-2015 | Current |
Financial Performance of Fitwel Pharmaceuticals.
Fitwel Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7.85% increase. The company also saw a substantial fall in profitability, with a 30.31% decrease in profit. The company's net worth Soared by an impressive increase of 33.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fitwel Pharmaceuticals?
Unlock access to Fitwel Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Gelmek Healthcare Private LimitedActive 6 years 3 monthsBhavik Jain and Kshitij Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Dec 2021 | ₹2.00 M | Open |
Hdfc Bank Limited Creation Date: 06 Dec 2021 | ₹0.44 M | Open |
Hdfc Bank Limited Creation Date: 09 Aug 2019 | ₹3.00 M | Open |
How Many Employees Work at Fitwel Pharmaceuticals?
Unlock and access historical data on people associated with Fitwel Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fitwel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fitwel Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
